Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
Klar
E
E
Department of Surgery, University of Heidelberg, Germany.
Theilmann
L
L
Hoffmann
V
V
Hofmann
W
W
Kraus
T
T
Mehrabi
A
A
Herfarth
C
C
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000097:blood*; D001663:Bilirubin / Q000097:blood; D001707:Biopsy, Needle; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies
D001647:Bile Acids and Salts; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001379:Azathioprine; D001663:Bilirubin; D008775:Methylprednisolone